Hugel Inc
145020
Company Profile
Business description
Hugel Inc is a biopharmaceutical company. It is in the business of manufacturing of biopharmaceuticals. The company's primary products are Botulinum toxin, Hyaluronic acid filler, and Cosmetics. It develops and promotes its products under the brand name of Wellage. The firm has manufacturing facilities in Shinbuk and Geodu.
Contact
61-20, Sinbuk-ro, Sinbuk-eup
ChuncheonGangwon24206
KORT: +82 332553882
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
609
Stocks News & Analysis
stocks
What does big US court decision mean for Google’s parent company Alphabet?
Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.
stocks
Is this still an ASX share to own forever?
Find out how this defensive player has fared after earnings.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,129.90 | 0.40 | 0.00% |
| CAC 40 | 7,698.92 | 20.79 | -0.27% |
| DAX 40 | 23,770.33 | 175.53 | 0.74% |
| Dow JONES (US) | 45,621.29 | 350.06 | 0.77% |
| FTSE 100 | 9,216.87 | 38.88 | 0.42% |
| HKSE | 25,183.49 | 124.98 | 0.50% |
| NASDAQ | 21,707.69 | 209.97 | 0.98% |
| Nikkei 225 | 42,923.91 | 343.64 | 0.81% |
| NZX 50 Index | 13,175.34 | 42.14 | 0.32% |
| S&P 500 | 6,502.08 | 53.82 | 0.83% |
| S&P/ASX 200 | 8,859.60 | 3.00 | -0.03% |
| SSE Composite Index | 3,778.76 | 12.89 | 0.34% |